![]() |
市場調査レポート
商品コード
1503390
内視鏡検査デバイス市場の2030年までの予測:製品タイプ別、治療・施術別、技術別、エンドユーザー別、地域別の世界分析Endoscopy Devices Market Forecasts to 2030 - Global Analysis By Product Type, Treatment & Procedure, Technology, End User and By Geography |
||||||
カスタマイズ可能
|
内視鏡検査デバイス市場の2030年までの予測:製品タイプ別、治療・施術別、技術別、エンドユーザー別、地域別の世界分析 |
出版日: 2024年06月06日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の内視鏡検査デバイス市場は2024年に319億米ドルを占め、予測期間中にCAGR 6.6%で成長し、2030年には468億米ドルに達する見込みです。
内視鏡検査デバイスは、体内の臓器や空洞を可視化し、診断し、治療介入を行うために使用される特殊な医療機器です。これらの器具は通常、先端にライトとカメラを備えた柔軟なチューブで構成されており、低侵襲的な処置が可能です。消化管、呼吸器系、生殖器などの領域を検査するため、消化器科、呼吸器科、婦人科で一般的に使用されています。
世界保健機関(WHO)によると、世界市場には推定200万種類の医療機器があり、7,000以上の汎用機器グループに分類されています。
慢性疾患の増加
胃腸障害、がん、心血管疾患などの慢性疾患の有病率の増加は、内視鏡検査デバイス市場の重要な促進要因です。これらの疾患は診断や治療のための内視鏡的処置を必要とすることが多く、内視鏡検査デバイスの需要増につながっています。内視鏡手術は、回復が早く合併症が少ない低侵襲なソリューションを提供できるため、その採用がさらに促進され、市場の成長を後押ししています。
内視鏡検査デバイスの高コスト
内視鏡検査デバイスの高コストが市場の大きな抑制要因となっています。高精細可視化システムやロボット支援内視鏡など、先進的な内視鏡検査デバイスやシステムには多額の値札が付いています。このため、特に予算に制約のある発展途上地域では導入が制限される可能性があります。また、初期投資やメンテナンスコストが高いことも、小規模なヘルスケア施設にとっては障壁となり、市場全体の成長に影響を与えています。
個別化医療へのシフト
個別化医療へのシフトは、内視鏡検査デバイス市場に大きなチャンスをもたらします。個別化医療では、患者一人ひとりの特性に合わせた治療が行われるため、正確な診断ツールが必要となります。内視鏡検査デバイスは、詳細な体内観察および標的生検が可能であり、個別化診断および治療処置に適しています。この動向は、高度な内視鏡技術の革新と採用を促進すると予想されます。
熟練した専門家の不足
熟練した専門家の不足は、内視鏡検査デバイス市場にとって顕著な脅威です。内視鏡処置は、正確な診断と効果的な治療を保証するために、高度な訓練を受けた経験豊富なヘルスケア専門家を必要とします。訓練された内視鏡医や技術者の不足は、高度な内視鏡検査デバイスの最適な利用を制限し、性能不足や潜在的な合併症を引き起こす可能性があります。この不足はまた、新技術の採用を妨げ、市場の成長を抑制します。
COVID-19パンデミックは内視鏡検査デバイス市場に大きな影響を与えました。パンデミックの初期段階では、COVID-19患者のためのリソースを優先し、ウイルス感染のリスクを減らすために、多くの内視鏡検査を含む選択的処置が延期または中止されました。このため、内視鏡検査デバイスに対する需要は一時的に減少しました。しかし、ヘルスケアシステムが適応し、安全対策が実施されるにつれて、延期されていた処置が再開され、早期診断の重要性に対する認識が高まったことにより、市場は回復し始めました。
予測期間中は内視鏡部門が最大となる見込み
予測期間中、内視鏡分野が最大となる見込み。内視鏡は、内視鏡処置で使用される主要なツールであり、内臓や組織の直接可視化を提供します。慢性疾患の有病率の増加や低侵襲処置への嗜好の高まりが、内視鏡の需要を牽引しています。高解像度画像や軟性内視鏡などの技術的進歩は、その有用性と採用をさらに強化し、市場成長に大きく寄与しています。
予測期間中、外来手術センター(ASCs)分野のCAGRが最も高くなる見込み
外来手術センター(ASCs)分野は、予測期間中に最も高いCAGRが見込まれます。ASCは、病院での手術に代わる費用対効果の高い効率的な選択肢を提供し、外来手術サービスを提供します。ASCで実施可能な低侵襲処置への嗜好の高まりが、こうした環境における内視鏡検査デバイスの需要を後押ししています。ASCに関連する利便性、入院期間の短縮、低コストは、患者やヘルスケアプロバイダーにとって魅力的な選択肢であり、市場の成長を後押ししています。
北米地域が内視鏡検査デバイス市場を独占しています。高度なヘルスケアインフラ、医療技術の採用率の高さ、消化器疾患や慢性疾患の罹患率の増加といった要因が、同地域の市場リーダーシップに寄与しています。主要市場プレイヤーの存在と内視鏡処置に対する有利な償還政策が北米の市場成長をさらに後押ししています。
アジア太平洋地域は内視鏡検査デバイス市場の急成長が期待されます。同地域の成長の原動力は、ヘルスケア投資の増加、医療インフラの改善、早期診断・治療に対する意識の高まりです。慢性疾患の有病率の高さ、高齢者人口の増加が内視鏡手術の需要を押し上げています。さらに、先進的な内視鏡技術の採用や、中国やインドなどの新興国におけるヘルスケアサービスの拡大も、この地域の高い成長率に寄与しています。
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
According to Stratistics MRC, the Global Endoscopy Devices Market is accounted for $31.9 billion in 2024 and is expected to reach $46.8 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Endoscopy devices are specialized medical instruments used to visualize, diagnose, and perform therapeutic interventions within the body's internal organs and cavities. These devices typically consist of a flexible tube with a light and a camera at the end, allowing for minimally invasive procedures. They are commonly employed in gastroenterology, pulmonology, and gynecology to inspect areas such as the gastrointestinal tract, respiratory system, and reproductive organs.
According to the World Health Organization (WHO), there are an estimated 2 million different kinds of medical devices on the world market, categorized into more than 7,000 generic device groups.
Increasing prevalence of chronic diseases
The rising prevalence of chronic diseases such as gastrointestinal disorders, cancer, and cardiovascular diseases is a significant driver for the endoscopy devices market. These conditions often require diagnostic and therapeutic endoscopic procedures, leading to increased demand for endoscopy devices. The ability of endoscopic procedures to provide minimally invasive solutions with quicker recovery times and fewer complications further boosts their adoption, driving market growth.
High cost of endoscopic equipment
The high cost of endoscopic equipment is a major restraint for the market. Advanced endoscopic devices and systems, such as high-definition visualization systems and robotic-assisted endoscopes, come with substantial price tags. This can limit their adoption, especially in developing regions with budget constraints. The high initial investment and maintenance costs can also be a barrier for smaller healthcare facilities, impacting overall market growth.
Shift towards personalized medicine
The shift towards personalized medicine presents a significant opportunity for the endoscopy devices market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, which requires precise diagnostic tools. Endoscopy devices, with their ability to provide detailed internal views and targeted biopsies, are well-suited for personalized diagnostic and therapeutic procedures. This trend is expected to drive innovation and adoption of advanced endoscopic technologies.
Lack of skilled professionals
The lack of skilled professionals is a notable threat to the endoscopy devices market. Endoscopic procedures require highly trained and experienced healthcare professionals to ensure accurate diagnosis and effective treatment. The shortage of trained endoscopists and technicians can limit the optimal utilization of advanced endoscopy equipment, leading to underperformance and potential complications. This shortage also hampers the adoption of new technologies, restraining market growth.
The Covid-19 pandemic had a significant impact on the endoscopy devices market. During the early stages of the pandemic, elective procedures, including many endoscopic examinations, were postponed or canceled to prioritize resources for Covid-19 patients and reduce the risk of viral transmission. This led to a temporary decline in demand for endoscopy devices. However, as healthcare systems adapted and implemented safety measures, the market began to recover, driven by the resumption of postponed procedures and increased awareness of the importance of early diagnosis.
The endoscopes segment is expected to be the largest during the forecast period
The endoscopes segment is expected to be the largest during the forecast period. Endoscopes are the primary tools used in endoscopic procedures, providing direct visualization of internal organs and tissues. The increasing prevalence of chronic diseases and the growing preference for minimally invasive procedures drive the demand for endoscopes. Technological advancements, such as high-definition imaging and flexible endoscopes, further enhance their utility and adoption, contributing significantly to market growth.
The ambulatory surgery centers (ASCs) segment is expected to have the highest CAGR during the forecast period
The ambulatory surgery centers (ASCs) segment is expected to have the highest CAGR during the forecast period. ASCs offer cost-effective and efficient alternatives to hospital-based surgeries, providing outpatient surgical services. The increasing preference for minimally invasive procedures, which can be performed in ASCs, drives the demand for endoscopy devices in these settings. The convenience, reduced hospital stay, and lower costs associated with ASCs make them an attractive option for patients and healthcare providers, fueling market growth.
The North America region is positioned to dominate the Endoscopy Devices Market. Factors such as advanced healthcare infrastructure, high adoption of medical technologies, and a growing incidence of gastrointestinal and chronic diseases contribute to the region's market leadership. The presence of key market players and favorable reimbursement policies for endoscopic procedures further supports market growth in North America.
The Asia Pacific region anticipates rapid growth in the Endoscopy Devices Market. The region's growth is driven by increasing healthcare investments, improving medical infrastructure, and rising awareness of early diagnosis and treatment. The high prevalence of chronic diseases, coupled with a growing geriatric population, boosts the demand for endoscopic procedures. Additionally, the adoption of advanced endoscopic technologies and the expansion of healthcare services in emerging economies like China and India contribute to the region's high growth rate.
Key players in the market
Some of the key players in Endoscopy Devices Market include Olympus Corporation, KARL STORZ SE & Co. KG, Boston Scientific Corporation, Johnson & Johnson (Ethicon), Stryker Corporation, Medtronic plc, Fujifilm Holdings Corporation, HOYA Corporation, Nipro Corporation, Smith & Nephew plc, Intuitive Surgical, Inc., Richard Wolf GmbH, Cook Medical, B. Braun Melsungen AG, ConMed Corporation, Ambu A/S, CapsoVision, Inc., Fortimedix Surgical B.V., The Cooper Companies, Inc. and Laborie Medical Technologies Inc.
In April 2024, Asensus Surgical, Inc. a medical device company that is digitizing the interface between the surgeon and the patient, announced that it has entered into a non-binding letter of intent (the "letter of intent") with KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company ("KARL STORZ") to engage in diligence and negotiations regarding the terms of a potential transaction whereby KARL STORZ may acquire Asensus. Entry into the letter of intent follows an extensive period of consideration of various strategic alternatives by Asensus, including potential collaboration and licensing transactions, a go-it-alone strategy dependent upon raising significant additional equity capital, a sale of the Company and other potential business development transactions.
In March 2024, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation, a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.
In October 2023, Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today the market launch of its next-generation EVIS X1(TM) endoscopy system, which will be on display and demonstrated Oct. 22-24 during the American College of Gastroenterology (ACG) annual meeting in Vancouver, Canada.